4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Viyash Scientific Limited (VIYASH) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Hyderabad, India with about 2,900 employees. Its market capitalization is roughly ₹110 billion. In the fiscal year ended 2026-03-31, VIYASH reported ₹33.6B in revenue and ₹1.8B in net income.
Viyash Scientific Limited operates as a veterinary pharmaceutical Company in India, the United States, Spain, and internationally. The company provides active pharmaceutical ingredients, finished dosage formulations, analytical services, and VET formulation services for cattle and poultry.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue | ₹33.6B | ₹29.6B | ₹13.7B | ₹14.2B |
| Gross Profit | ₹16.3B | ₹13.4B | ₹5.5B | ₹5.2B |
| Operating Income (EBIT) | ₹4.5B | ₹1.8B | ₹370M | ₹3M |
| Net Income | ₹1.8B | ₹232M | (₹359M) | (₹1.2B) |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹9.5B | ₹9.2B | ₹8.6B | ₹4.2B | ₹7.9B | — |
| Gross Profit | ₹5.1B | ₹5.1B | ₹4.7B | ₹2.1B | ₹4.1B | — |
| Operating Income (EBIT) | ₹1.2B | ₹1.3B | ₹1.2B | ₹410M | ₹595M | — |
| Net Income | ₹659M | ₹521M | ₹384M | ₹147M | ₹318M | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | — | — | — | — | (₹123M) |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹46.3B | ₹41.3B | ₹15.4B | ₹15.3B | — |
| Total Liabilities | ₹15.1B | ₹15.7B | ₹8.3B | ₹7.8B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive VIYASH viewer.
About TickerBase · Data methodology & sources · Privacy · Terms